Form D Explorer
Sofinnova BioEquities Enhanced Master Fund, LP · CIK 1949475

Report a data issueCitable research briefCompare issuerPrivate research collection

Sofinnova BioEquities Enhanced Master Fund, LP

CIK 1949475 · Limited Partnership · Inc. DELAWARE · MENLO PARK, California · Pooled Investment Fund

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
0
Amendments
2
Activity
Oct 10, 2025
through Oct 9, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldOct 10, 2025 · D/AOct 9, 2026 · D/ALater minus earlier
Reported offering amount———
Reported amount sold$41,545,600$87,225,567$45,679,967
Reported investor count—26—
Reported minimum investment$0$0$0

Earlier SEC source: 0000919574-25-006040 · Later SEC source: 0000919574-26-006827

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Oct 9, 2026

Reported offering amount
—
Reported exemptions
Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(7)
Reported amount sold
$87,225,567

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Related person name and locality match

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (2)